Market intelligence across pharma, MedTech, and digital health.
3,460+ published studies covering therapeutics, diagnostics, devices, and healthcare services — sized bottom-up and top-down, validated by our dedicated Healthcare & Medical Devices research team, and delivered with country-level detail.
The Healthcare & Medical Devices Research Team
This vertical is covered by a dedicated research group inside Fundamental Business Insights that tracks the global healthcare and medical technology industry full-time. Our analysts follow clinical adoption trends, regulatory developments, reimbursement policy, healthcare infrastructure investment, and evolving patient-care requirements as they happen — not just at the point a report is commissioned.
Every estimate in this vertical is built from primary conversations with healthcare stakeholders and cross-checked against company financial disclosures, regulatory publications, clinical literature, and government health databases, then reconciled through both bottom-up and top-down modeling before an internal quality review.
Who we interview
Clinical KOLs, regulatory affairs heads, hospital procurement leads, and MedTech product & commercial teams.
Regulatory fluency
Analysts track FDA, EMA, and regional approval pathways so device and drug forecasts reflect real timelines.
Reimbursement modeling
Forecasts factor in payer policy and reimbursement shifts, not just clinical or technology adoption curves.
Sub-domains we track
Healthcare & Medical Devices reports on this site span the following sub-domains. Reports aren't filed under these as separate sub-categories yet — search or browse the full list below to find a specific market.
Pharmaceuticals
Small-molecule and branded/generic drug markets across therapeutic areas and dosage forms.
Biotechnology & Advanced Therapies
Cell and gene therapies, biologics, and next-generation biotech platforms.
Medical Devices
Diagnostic, surgical, monitoring, and implantable device categories across care settings.
Medical Diagnostics
In-vitro diagnostics, imaging, and point-of-care testing markets.
Analytical & Laboratory Technologies
Lab instrumentation, reagents, and analytical platforms used in research and clinical settings.
Healthcare IT & Digital Health
EHR platforms, telehealth, remote monitoring, and clinical software markets.
Clinical & Healthcare Services
Hospital operations, outpatient care, and healthcare service delivery models.
Veterinary Healthcare
Animal health diagnostics, pharmaceuticals, and veterinary device markets.
Life Science Research Tools
Instruments, reagents, and platforms supporting pharmaceutical and academic research.
Secondary sources behind this vertical
Alongside primary interviews, every Healthcare & Medical Devices estimate is checked against these authoritative public and regulatory sources.
| Secondary source | Official website |
|---|---|
| World Health Organization (WHO) | who.int ↗ |
| U.S. Food & Drug Administration (FDA) | fda.gov ↗ |
| European Medicines Agency (EMA) | ema.europa.eu ↗ |
| Centers for Disease Control and Prevention (CDC) | cdc.gov ↗ |
| National Institutes of Health (NIH) | nih.gov ↗ |
| National Center for Biotechnology Information (NCBI) | ncbi.nlm.nih.gov ↗ |
| PubMed | pubmed.ncbi.nlm.nih.gov ↗ |
| ClinicalTrials.gov | clinicaltrials.gov ↗ |
| International Organization for Standardization (ISO) | iso.org ↗ |
| ASTM International | astm.org ↗ |
| Advanced Medical Technology Association (AdvaMed) | advamed.org ↗ |
| Medical Device Innovation Consortium (MDIC) | mdic.org ↗ |
| Biotechnology Innovation Organization (BIO) | bio.org ↗ |
| Int'l Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | ifpma.org ↗ |
| U.S. Pharmacopeia (USP) | usp.org ↗ |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | edqm.eu ↗ |
| World Organisation for Animal Health (WOAH) | woah.org ↗ |
| American Hospital Association (AHA) | aha.org ↗ |
| OECD Health | oecd.org/health ↗ |
| World Bank Data | data.worldbank.org ↗ |
Lipid Nanoparticles Market Size & Forecasts 2026-2035, By Segments (Type, End-User, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (BioNTech, Moderna, Pfizer, Acuitas Therapeutics, CordenPharma)
Lipid Nanoparticles Market size is forecast to climb from USD 1.05 billion in 2025 to USD 2.8 billion by 2035, expanding at a CAGR of over 10.3% during 2026-2035. Industry revenue...
Rare Disease Genetic Testing Market Size & Forecasts 2026-2035, By Segments (Specialty, End-Use, Technology, Disease Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Invitae, Fulgent Genetics, Myriad Genetics, Natera, Centogene)
Rare Disease Genetic Testing Market size is projected to grow steadily from USD 591.43 million in 2025 to USD 1.22 billion by 2035, demonstrating a CAGR exceeding 7.5% through the...
Antithrombin Market Size & Forecasts 2026-2035, By Segments (Source, Dosage Form, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Grifols, LFB, Kedrion Biopharma, Octapharma, Sanquin)
Antithrombin Market size is expected to advance from USD 671.02 million in 2025 to USD 1.09 billion by 2035, registering a CAGR of more than 5% across 2026-2035. By 2026, the indus...
Human Microbiome Market Size & Forecasts 2026-2035, By Segments (Application, Product, Disease Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Enterome, Seres Therapeutics, Finch Therapeutics, 4D Pharma, Synlogic)
Human Microbiome Market size is anticipated to rise from USD 1.15 billion in 2025 to USD 12.85 billion by 2035, reflecting a CAGR surpassing 27.3% over the forecast horizon of 2026...
Alcoholic Hepatitis Therapeutics Market Size & Forecasts 2026-2035, By Segments (Distribution Channel, Product Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Gilead Sciences, Johnson & Johnson, AbbVie, Mallinckrodt Pharmaceuticals, NGM Biopharmaceuticals)
Alcoholic Hepatitis Therapeutics Market size is predicted to expand from USD 193.12 million in 2025 to USD 1.32 billion by 2035, with growth underpinned by a CAGR above 21.2% betwe...
Stem Cell Manufacturing Market Size & Forecasts 2026-2035, By Segments (Application, End User, Product), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Lonza, Thermo Fisher Scientific, Sartorius, Miltenyi Biotec, >STEMCELL Technologies)
Stem Cell Manufacturing Market size is estimated to increase from USD 736.71 million in 2025 to USD 2.23 billion by 2035, supported by a CAGR exceeding 11.7% during 2026-2035. In 2...
Custom Antibody Market Size & Forecasts 2026-2035, By Segments (End-User, Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, GenScript)
Custom Antibody Market size is projected to expand significantly, moving from USD 605.59 million in 2025 to USD 1.34 billion by 2035, with a CAGR of 8.3% during the 2026-2035 forec...
Patient Identification Wristbands Market Size & Forecasts 2026-2035, By Segments (Age Group, Product Type, Material, End User, Closure), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Zebra Technologies, Avery Dennison, Brady Corporation, Alpha Numeric Systems, 3M)
Patient Identification Wristbands Market size is set to grow from USD 541.37 million in 2025 to USD 1.2 billion by 2035, reflecting a CAGR greater than 8.3% through 2026-2035. Indu...
Medical Nitroglycerin Sprays Market Size & Forecasts 2026-2035, By Segments (Application, Metered-Dose, Distribution Channel), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Pfizer, Bayer, Mylan, Teva Pharmaceuticals, Sandoz)
Medical Nitroglycerin Sprays Market size is forecasted to reach USD 2.22 billion by 2035, rising from USD 944.77 million in 2025, at a CAGR of more than 8.9% between 2026 and 2035....
Telerehabilitation Systems Market Size & Forecasts 2026-2035, By Segments (End User, Type), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (RehabLight, Bionik Laboratories, Hocoma, Tyromotion, Saebo)
Telerehabilitation Systems Market size is likely to expand from USD 900.52 million in 2025 to USD 1.75 billion by 2035, posting a CAGR above 6.9% across 2026-2035. The industry’s r...
Need an Industry Research study we haven't published yet?
Our Healthcare team scopes custom studies using the same interview network and validation framework — typically delivered in 2–3 weeks.